
VITALOOP
Vitaloop explores the possibility of checking blood sugar levels through non-invasive methods using NIR sensing technology.
A non-invasive glucose-monitoring wearable designed to support Type 1 diabetic athletes during training and endurance activity.
Vitaloop is a wrist-worn health-tech concept created to help athletes with Type 1 diabetes monitor glucose changes more comfortably during exercise. The project focuses on reducing the need for constant finger-prick checks during activity while giving users clearer awareness of potential hypoglycemia risk.
The concept explores near-infrared spectroscopy, using multiple LED wavelengths and a photosensor to estimate glucose-related changes through the skin. Research shows that NIR spectroscopy studies light that is scattered, transmitted, or reflected from tissue, and that glucose-related molecular bonds can affect how certain NIR wavelengths are absorbed and reflected.
Loughborough School of Design and Creative Arts
Duration - 8 weeks
01
Process
Background

For athletes with Type 1 diabetes, exercise can make glucose control more unpredictable. During running, cycling, gym training, or endurance sport, blood glucose may drop quickly, increasing the risk of hypoglycemia.
The challenge is that many symptoms of low glucose, such as sweating, tiredness, dizziness, increased heart rate, and weakness, can feel very similar to normal exercise fatigue. This makes it harder for an athlete to recognise when their body is entering a risky state.
Existing solutions such as finger-prick meters and continuous glucose monitors are useful, but they can feel invasive, medical, expensive, or inconvenient during sport. Vitaloop was developed as a more discreet, athlete-focused wearable concept that fits naturally into a sports lifestyle.
Problem
Type 1 diabetic athletes need a faster and more accessible way to understand glucose changes during physical activity.
The key problems identified were:
-
Exercise can hide symptoms of hypoglycemia. Sweating, tiredness, and high heart rate are normal during sport, but they are also warning signs of low glucose.
-
Finger-prick testing interrupts activity.
Checking glucose manually during training can be inconvenient, uncomfortable, and difficult while moving.
-
Existing devices often feel medical.
Many glucose-monitoring products are designed mainly for clinical use, not for athletes, performance, or everyday confidence.
-
Athletes need trend awareness, not just numbers.
During exercise, the user needs quick warnings, simple feedback, and clear visual alerts rather than complex medical information.

Design Opportunity
The opportunity was to design a wearable that feels closer to a sports smartwatch than a medical device.
Vitaloop aims to give athletes a more natural way to track glucose trends during exercise by combining non-invasive optical sensing, simple feedback, and a comfortable wrist-worn form.
The design intent was to create a product that is:
-
Discreet enough for daily wear
-
Comfortable during sport
-
Easy to read while moving
-
Less invasive than finger-prick testing
-
Focused on confidence, safety, and independence
Technology Research
Vitaloop explores a multi-wavelength near-infrared sensing system.
The device uses three different NIR LED wavelengths, such as 940 nm, 1350 nm, and 1400 nm, directed into the skin. Each wavelength interacts with tissue, blood, water, and glucose-related molecules in a slightly different way. Some wavelengths pass through tissue more easily, while others are absorbed or scattered more strongly.
A photodiode sensor receives the light that reflects back from the skin. The amount of light received changes depending on how much light was absorbed or scattered inside the tissue. This creates a signal that can be processed by the device.
The basic sensing process is:
1. NIR LEDs emit light into the wrist.
Three different wavelengths are used because each wavelength responds differently to tissue and glucose-related absorption.
2. Light passes into the skin and interacts with tissue.
As the light enters the skin, it is partly absorbed and partly scattered by blood, water, skin layers, and glucose-related molecules.
3. A photodiode receives the reflected light.
The sensor measures the remaining light intensity returning from the tissue.
4. The system compares the three readings.
By comparing how much light returns from each wavelength, the device can detect changes in the optical signal.
5. An algorithm estimates glucose trends.
The readings are processed and calibrated against reference glucose values to estimate whether glucose is stable, rising, or falling.
This method is based on the principle that NIR-based systems commonly use a light source, tissue interaction, and a photodiode detector to measure attenuated or reflected light. Research also shows that prototype NIR glucose systems have used wavelengths such as 940 nm, 1300 nm, 1350 nm, and similar ranges for glucose-estimation studies.

Exploration
I explored different concepts via sketching and prototyping and validated ideas with users and experts.










Concept Validation

To explore the sensing principle behind Vitaloop, I first built a 3D-printed testing jig that could hold a liquid sample in a fixed position. The setup included LED light sources, a photodiode sensor, a breadboard circuit, and a small sample holder. This allowed me to test the system in a controlled way before moving towards human-based testing.
For the first stage, I used distilled water mixed with measured amounts of glucose. This created a simple glucose-water solution where the concentration could be changed and compared. The LEDs passed light through the sample, while the photodiode measured how much light was received back. As the glucose concentration changed, the sensor output also changed, showing that the optical signal was reacting to differences in the sample.
This helped prove the basic working principle: light enters the sample, interacts with the liquid and glucose molecules, and the reflected or transmitted light is captured by the photodiode as a readable signal. The readings from the glucose-water test were then used as a starting reference to understand how the system could be adapted toward human blood and skin.
However, human use is much more complex than testing in water. Skin layers, blood flow, tissue density, water content, movement, and external light can all affect the reading. Because of this, the prototype was not treated as a medically accurate device, but as an early proof-of-principle model to explore whether non-invasive optical sensing could detect glucose-related trends.
This stage helped guide the sensor placement, jig design, and future direction of the Vitaloop wearable.
02
Final Design
Vitaloop
Vitaloop is a wearable healthcare concept designed to help athletes with Type 1 diabetes monitor glucose trends during physical activity. Combining user-centred design with experimental near-infrared (NIR) sensing technology, the project explores the possibility of measuring blood glucose non-invasively. Through research, prototyping, and testing, Vitaloop aims to make glucose monitoring more accessible, comfortable, and seamlessly integrated into an athlete’s lifestyle.

Design Philosophy
Vitaloop bridges the gap between medical functionality and everyday sports wearables. Inspired by contemporary smartwatches, its compact circular housing, smooth surfaces, and minimal aesthetic create an approachable product that feels less like medical equipment and more like a lifestyle accessory.



Ergonomics & Wearability
Designed for active movement, Vitaloop features a lightweight housing and a flexible, ventilated silicone strap to improve comfort and breathability. The adjustable fit helps maintain consistent contact between the optical sensor and the skin, an important consideration for reliable measurements.


Optical Sensing Integration
The concept explores three NIR wavelengths — 940 nm, 1350 nm, and 1400 nm — alongside a photodiode sensor. Light interacts with skin and underlying tissue before being scattered back towards the sensor, where the resulting signals could be analysed to estimate glucose trends. Further testing and calibration would be required to establish accuracy.







